Silverarc Capital Management

Silverarc Capital Management as of March 31, 2023

Portfolio Holdings for Silverarc Capital Management

Silverarc Capital Management holds 68 positions in its portfolio as reported in the March 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Merus NV Equities (MRUS) 5.1 $12M 669k 18.40
MacroGenics Equities (MGNX) 4.0 $9.8M 1.4M 7.17
89bio Equities (ETNB) 4.0 $9.7M 638k 15.23
Viewray Equities (VRAYQ) 4.0 $9.7M 2.8M 3.46
Poseida Therapeutics Equities (PSTX) 3.4 $8.3M 2.7M 3.08
Oric Pharmaceuticals Equities (ORIC) 3.4 $8.2M 1.4M 5.70
Pliant Therapeutics Equities (PLRX) 3.3 $8.0M 300k 26.60
Terns Pharmaceuticals Equities (TERN) 3.3 $7.9M 668k 11.84
Akero Therapeutics Equities (AKRO) 3.2 $7.7M 203k 38.26
Nuvalent Equities (NUVL) 3.0 $7.3M 282k 26.09
Bellus Health Equities 3.0 $7.2M 1.0M 7.20
Aclaris Therapeutics Equities (ACRS) 2.9 $7.1M 872k 8.09
Intra-Cellular Therapies Equities (ITCI) 2.8 $6.8M 125k 54.15
Viking Therapeutics Equities (VKTX) 2.6 $6.3M 380k 16.65
Cogent Biosciences Equities (COGT) 2.6 $6.3M 579k 10.79
Karyopharm Therapeutics Equities (KPTI) 2.5 $6.0M 1.5M 3.89
KalVista Pharmaceuticals Equities (KALV) 2.3 $5.7M 724k 7.86
Schrodinger Equities (SDGR) 2.3 $5.6M 213k 26.33
Gilead Sciences Equities (GILD) 2.1 $5.0M 60k 82.97
ImmunoGen Equities 2.0 $4.9M 1.3M 3.84
BioCryst Pharmaceuticals Equities (BCRX) 2.0 $4.8M 578k 8.34
Veracyte Equities (VCYT) 1.9 $4.7M 210k 22.30
Pharvaris NV Equities (PHVS) 1.9 $4.5M 559k 8.05
United Therapeutics Corp Equities (UTHR) 1.7 $4.2M 19k 223.96
Vertex Pharmaceuticals Equities (VRTX) 1.7 $4.2M 13k 315.07
Regeneron Pharmaceuticals Equities (REGN) 1.7 $4.1M 5.0k 821.67
Xenon Pharmaceuticals Equities (XENE) 1.4 $3.5M 97k 35.79
Cerus Corp Equities (CERS) 1.4 $3.4M 1.2M 2.97
Biogen Idec Equities (BIIB) 1.3 $3.1M 11k 278.03
Celldex Therapeutics Equities (CLDX) 1.3 $3.0M 85k 35.98
Alnylam Pharmaceuticals Equities (ALNY) 1.2 $2.8M 14k 200.32
Krystal Biotech Equities (KRYS) 1.1 $2.7M 34k 80.06
Cullinan Oncology Equities (CGEM) 1.1 $2.7M 265k 10.23
Mirum Pharmaceuticals Equities (MIRM) 1.1 $2.5M 106k 24.02
Incyte Corp Equities (INCY) 1.0 $2.5M 34k 72.27
Insmed Equities (INSM) 1.0 $2.5M 144k 17.05
Protagonist Therapeutics Equities (PTGX) 1.0 $2.4M 106k 23.00
Madrigal Pharmaceuticals Equities (MDGL) 1.0 $2.4M 10k 242.26
Ventyx Biosciences Equities (VTYX) 1.0 $2.3M 70k 33.50
MoonLake Immunotherapeutics Equities (MLTX) 0.9 $2.3M 106k 21.39
Mersana Therapeutics Equities (MRSN) 0.9 $2.2M 540k 4.11
Immatics Nv Equities (IMTX) 0.8 $1.9M 282k 6.90
Morphic Holding Equities (MORF) 0.8 $1.9M 52k 37.64
Altimmune Long Option Calls Call Option (ALT) 0.7 $1.8M 416k 4.22
Trevi Therapeutics Equities (TRVI) 0.7 $1.6M 886k 1.85
Prometheus Biosciences Equities 0.6 $1.5M 14k 107.32
Point Biopharma Global Equities 0.6 $1.4M 199k 7.27
Phathom Pharmaceuticals Equities (PHAT) 0.6 $1.4M 200k 7.14
Intellia Therapeutics Equities (NTLA) 0.6 $1.4M 38k 37.27
Eliem Therapeutics Equities (ELYM) 0.6 $1.4M 486k 2.90
Seres Therapeutics Equities (MCRB) 0.5 $1.3M 233k 5.67
Sarepta Therapeutics Equities (SRPT) 0.5 $1.3M 9.3k 137.83
Astria Therapeutics Equities (ATXS) 0.5 $1.2M 94k 13.30
Cue Biopharma Equities (CUE) 0.5 $1.1M 306k 3.57
Allakos Equities (ALLK) 0.4 $939k 211k 4.45
Viridian Therapeutics Equities (VRDN) 0.4 $926k 36k 25.44
Jasper Therapeutics Equities 0.4 $905k 500k 1.81
Bridgebio Pharma Equities (BBIO) 0.3 $663k 40k 16.58
Acumen Pharmaceuticals Equities (ABOS) 0.2 $597k 147k 4.06
Tela Bio Equities (TELA) 0.2 $576k 54k 10.64
Aligos Therapeutics Equities (ALGS) 0.2 $552k 632k 0.87
Cvrx Equities (CVRX) 0.1 $280k 30k 9.32
Monte Rosa Therapeutics Equities (GLUE) 0.1 $243k 31k 7.79
LAVA Therapeutics NV Equities (LVTX) 0.1 $233k 140k 1.66
Compugen Equities (CGEN) 0.1 $232k 330k 0.70
Eloxx Pharmaceuticals Equities (ELOX) 0.1 $136k 54k 2.51
Rocket Pharmaceuticals Warrants (RCKTW) 0.0 $12k 105k 0.11
Fresh Tracks Therapeutics Equities (FRTX) 0.0 $6.6k 10k 0.66